Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 11/20 | 0.56 |
| ▸ | CCND1 | P24385 | 11/20 | 0.56 |
| ▸ | CCNE1 | P24864 | 7/20 | 0.56 |
| ▸ | CDK2 | P24941 | 7/20 | 0.56 |
| ▸ | CDK1 | P06493 | 6/20 | 0.56 |
| ▸ | CCNB1 | P14635 | 6/20 | 0.56 |
| ▸ | CCND2 | P30279 | 1/20 | 0.44 |
| ▸ | CCND3 | P30281 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 5/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 3/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6088805 | 0.88 | CDK4 (0.51) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL6087469 | 0.87 | CDK4 (0.51) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL6086786 | 0.85 | CDK4 (0.56) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL6087731 | 0.85 | EGFR (0.44) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL6089773 | 0.85 | CDK4 (0.53) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL6086302 | 0.82 | CDK4 (0.56) | CDK4CCND1CCNE1CDK2SYK | |
| SCHEMBL7463398 | 0.81 | EGFR (0.42) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL6087447 | 0.81 | CDK2 (0.58) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL6087733 | 0.80 | EGFR (0.39) | CDK4CCND1CCNE1CDK2CDK1 | |
| SCHEMBL7472695 | 0.80 | EGFR (0.42) | CDK4CCND1CCNE1CDK2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1235815-A1 | QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES | WARNER-LAMBERT COMPANY (US) | 2002-09-04 | — | — | EP | claimed |
| WO-2001038315-A1 | QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES | WARNER-LAMBERT COMPANY (US) | 2001-05-31 | — | — | WO | claimed |
| US-6982260-B1 | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes | WARNER-LAMBERT COMPANY (US) | 2006-01-03 | — | — | US | disclosed |
| EP-1235815-A1 | QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES | WARNER-LAMBERT COMPANY (US) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001038315-A1 | QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES | WARNER-LAMBERT COMPANY (US) | 2001-05-31 | — | — | WO | disclosed |